Morgan Stanley’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.16M | Buy |
|
|||||
|
2025
Q1 | $4.26M | Sell |
|
|||||
|
2024
Q4 | $7.87M | Buy |
|
|||||
|
2024
Q3 | $9.58M | Buy |
|
|||||
|
2024
Q2 | $9.37M | Buy |
|
|||||
|
2024
Q1 | $12.2M | Buy |
|
|||||
|
2023
Q4 | $2.6M | Buy |
|
|||||
|
2023
Q3 | $596K | Buy |
|
|||||
|
2023
Q2 | $1.4M | Buy |
|
|||||
|
2023
Q1 | $854K | Buy |
|
|||||
|
2022
Q4 | $1.35M | Buy |
|
|||||
|
2022
Q3 | $1.36M | Buy |
|
|||||
|
2022
Q2 | $1.63M | Buy |
|
|||||
|
2022
Q1 | $1.26M | Buy |
|
|||||
|
2021
Q4 | $1.43M | Sell |
|
|||||
|
2021
Q3 | $2.3M | Sell |
|
|||||
|
2021
Q2 | $6.08M | Buy |
|
|||||
|
2021
Q1 | $4.99M | Buy |
|
|||||
|
2020
Q4 | $3.52M | Buy |
|
|||||
|
2020
Q3 | $346K | Sell |
|
|||||
|
2020
Q2 | $589K | Buy |
|